# HCA Healthcare, Inc.: Form 10-Q for the period ended Mar 31, 2022

- Company: [HCA Healthcare, Inc.](/companies/hca.md) (CIK 860730)
- Form: 10-Q
- Filed: 2022-05-03
- Accepted by EDGAR: May 3, 2022, 16:31 ET
- Period: 2022-03-31
- Accession: 0000950170-22-007089
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/860730/000095017022007089/hca-20220331.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/860730/000095017022007089/

## Figures reported in this filing

Standardized XBRL line items for the period ended 2022-03-31.

| Line item | Period | Value | XBRL concept |
| --- | --- | ---: | --- |
| Revenue | 3 months, 2022-01-01 to 2022-03-31 | $14.95bn | us-gaap:Revenues |
| Interest expense | 3 months, 2022-01-01 to 2022-03-31 | $408.0m | us-gaap:InterestExpense |
| Income tax | 3 months, 2022-01-01 to 2022-03-31 | $349.0m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months, 2022-01-01 to 2022-03-31 | $1.27bn | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months, 2022-01-01 to 2022-03-31 | $4.14 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months, 2022-01-01 to 2022-03-31 | $4.21 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months, 2022-01-01 to 2022-03-31 | 307,374,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 3 months, 2022-01-01 to 2022-03-31 | $1.34bn | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 3 months, 2022-01-01 to 2022-03-31 | $861.0m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Dividends paid | 3 months, 2022-01-01 to 2022-03-31 | $177.0m | us-gaap:PaymentsOfDividends |
| Share repurchases | 3 months, 2022-01-01 to 2022-03-31 | $2.10bn | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | at 2022-03-31 | $2.37bn | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | at 2022-03-31 | $15.01bn | us-gaap:AssetsCurrent |
| Total assets | at 2022-03-31 | $52.21bn | us-gaap:Assets |
| Current liabilities | at 2022-03-31 | $10.52bn | us-gaap:LiabilitiesCurrent |
| Long-term debt | at 2022-03-31 | $36.21bn | us-gaap:LongTermDebtNoncurrent |
| Current portion of debt | at 2022-03-31 | $1.49bn | us-gaap:LongTermDebtCurrent |
| Shareholders' equity | at 2022-03-31 | −$2.03bn | us-gaap:StockholdersEquity |

## Sections

The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. https://www.sec.gov/Archives/edgar/data/860730/000095017022007089/hca-20220331.htm

Filed May 3, 2022.
Source: SEC EDGAR, the filing index for accession 0000950170-22-007089. Last ingested by Listed: Nov 11, 2026, 03:15 ET. No prices; not investment advice.
